LEXINGTON, Mass.--(BUSINESS WIRE)--May 23, 2006--Critical Therapeutics, Inc. (NASDAQ: CRTX - News), a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, today announced that two scientific posters related to its asthma drug, ZYFLO® (zileuton tablets), will be presented at the 2006 International Conference of the American Thoracic Society in San Diego.
